Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
An update from Tsumura & Co ( (JP:4540) ) is now available.
Tsumura & Co reported a significant increase in its consolidated financial results for the fiscal year ended March 31, 2025, with net sales rising by 20.1% and operating profit doubling compared to the previous year. The company’s strong performance is reflected in its increased dividends and improved financial condition, indicating a robust market position and positive outlook for stakeholders.
More about Tsumura & Co
Tsumura & Co is a company listed on the Tokyo Stock Exchange, primarily operating in the pharmaceutical industry. It specializes in the production and distribution of traditional Japanese Kampo medicines, focusing on providing herbal remedies to the market.
YTD Price Performance: -6.24%
Average Trading Volume: 369,950
Technical Sentiment Signal: Buy
Current Market Cap: Yen332.6B
Find detailed analytics on 4540 stock on TipRanks’ Stock Analysis page.